134 related articles for article (PubMed ID: 21162904)
61. Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression.
Feng F; Qiu B; Zang R; Song P; Gao S
Oncotarget; 2017 Apr; 8(17):29091-29100. PubMed ID: 28404970
[TBL] [Abstract][Full Text] [Related]
62. [Effect of stomatin-like protein 2 (SLP-2) gene on growth and proliferation of esophageal squamous carcinoma cell line TE12].
Zhang LY; Ding F; Liu ZM; Li WD; Liu ZH; Li YD
Ai Zheng; 2005 Feb; 24(2):155-9. PubMed ID: 15694024
[TBL] [Abstract][Full Text] [Related]
63. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
Wong VC; Chan PL; Bernabeu C; Law S; Wang LD; Li JL; Tsao SW; Srivastava G; Lung ML
Int J Cancer; 2008 Dec; 123(12):2816-23. PubMed ID: 18798555
[TBL] [Abstract][Full Text] [Related]
64. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Cui G; Liu D; Li W; Li Y; Liang Y; Shi W; Zhao S
Exp Biol Med (Maywood); 2017 Jan; 242(1):45-52. PubMed ID: 27480251
[TBL] [Abstract][Full Text] [Related]
65. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460
[TBL] [Abstract][Full Text] [Related]
66. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.
Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J
Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796
[TBL] [Abstract][Full Text] [Related]
67. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
68. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
[TBL] [Abstract][Full Text] [Related]
70. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms.
Han G; Lu K; Huang J; Ye J; Dai S; Ye Y; Zhang L
Int J Mol Med; 2017 Feb; 39(2):357-363. PubMed ID: 28035369
[TBL] [Abstract][Full Text] [Related]
71. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
72. CRCT1 regulated by microRNA-520 g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.
Wu N; Song Y; Pang L; Chen Z
Tumour Biol; 2016 Jun; 37(6):8271-9. PubMed ID: 26718216
[TBL] [Abstract][Full Text] [Related]
73. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
[TBL] [Abstract][Full Text] [Related]
74. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer.
Zhang H; Zhao JH; Suo ZM
Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137
[TBL] [Abstract][Full Text] [Related]
75. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
76. Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.
Mao L; Li X; Gong S; Yuan H; Jiang Y; Huang W; Sun X; Dang X
Cancer Gene Ther; 2018 Oct; 25(9-10):248-259. PubMed ID: 29983418
[TBL] [Abstract][Full Text] [Related]
77. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
Götze S; Feldhaus V; Traska T; Wolter M; Reifenberger G; Tannapfel A; Kuhnen C; Martin D; Müller O; Sievers S
BMC Cancer; 2009 Dec; 9():447. PubMed ID: 20017917
[TBL] [Abstract][Full Text] [Related]
78. Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.
Li L; Wang W; Li X; Gao T
Am J Transl Res; 2017; 9(8):3741-3748. PubMed ID: 28861165
[TBL] [Abstract][Full Text] [Related]
79. The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury.
Shaterian A; Kao S; Chen L; DiPietro LA; Coimbra R; Eliceiri BP; Baird A
Arch Dermatol Res; 2013 Mar; 305(2):141-9. PubMed ID: 22899245
[TBL] [Abstract][Full Text] [Related]
80. Molecular biology of esophageal squamous cell carcinoma.
Lam AK
Crit Rev Oncol Hematol; 2000 Feb; 33(2):71-90. PubMed ID: 10737369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
